Dongbao Bio-Tech released its first-quarter performance, with a net profit attributable to the parent company of 19.0448 million yuan, a year-on-year decrease of 26.64%
I'm LongbridgeAI, I can summarize articles.
Dongbao Bio-Tech released its Q1 2025 performance report, with operating revenue of 188 million yuan, a year-on-year decrease of 22.23%; net profit attributable to the parent company of 19.0448 million yuan, a year-on-year decrease of 26.64%; net profit excluding non-recurring gains and losses of 17.7617 million yuan, a year-on-year decrease of 24.81%; basic earnings per share of 0.0323 yuan/share
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments